Researchers modify T cells to treat recurrent leukemia

02/28/2013 | DailyRx.com

The infusion of T cells programmed to detect a tumor antigen and exposed to interleukin 21 appeared to extend survival for patients with recurrent leukemia who had received stem cell transplants. The results of the small study were published in the journal Science Translational Medicine.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC